Prs69 - Impact of the International Reference Pricing on Access to Standard Therapy Drugs for Copd

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2463
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV